Cero Therapeutics Holdings CERO
OTC CERO
$0.00 0.00 (-19.61%)
As of: Oct 23, 2026 · 12:24 PM EDT

Cero Therapeutics Holdings (CERO) Cash from Investing Activities (2022 - 2023)

Updated

Cero Therapeutics Holdings' Cash from Investing Activities was $500,000 in FY2025.

Analysis

Cero Therapeutics Holdings (CERO) Cash from Investing Activities (2022 - 2023) Analysis & Trends

From FY2021 onward, Cero Therapeutics Holdings has reported Cash from Investing Activities for 4 years.

  • The FY2025 figure marks the highest annual Cash from Investing Activities since FY2022.
  • Per Business Quant data, Cash from Investing Activities in earlier years was -$7.94 million in FY2023, $180.84 million in FY2022 and -$178.5 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -2.71 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -1.20 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.11 Bn
10 Cero Therapeutics Holdings 210,875.10 -5.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -13.82 Mn
Sep 30, 2023 5.69 Mn
Jun 30, 2023 285,236.00
Mar 31, 2023 -100,000.00
Dec 31, 2022 180.71 Mn
API Access

Cero Therapeutics Holdings Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CERO&period=max&api_key=YOUR_API_KEY